For example, proteomics studies using patient tissue reveal that Wnt signaling components are increased during AD progression (Bai et al, 2020), while other studies show a reduction of LRP6 and β-catenin mRNA and protein in AD brains (Liu et al, 2014). This evidence concerns the gene LRP6 and Alzheimer disease.